Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
| Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and Sloan-Kettering Institute for Cancer Research |
| Hetero Labs Limited Unit V and Hetero USA, Inc. |
| 1:2022cv00696 |
| May 27, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 5, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 NOTICE of Appearance by April M Ferraro on behalf of Hetero Labs Limited Unit V, Hetero USA, Inc. (Ferraro, April) |
| Filing 10 NOTICE of Appearance by John M. Seaman on behalf of Hetero Labs Limited Unit V, Hetero USA, Inc. (Seaman, John) |
| Filing 9 WAIVER OF SERVICE returned executed by Janssen Biotech, Inc., Aragon Pharmaceuticals, Inc., The Regents of the University of California, Sloan-Kettering Institute for Cancer Research: For Hetero USA, Inc. waiver sent on 6/3/2022, answer due 8/2/2022. (Blumenfeld, Jack) |
| Filing 8 WAIVER OF SERVICE returned executed by Janssen Biotech, Inc., Aragon Pharmaceuticals, Inc., The Regents of the University of California, Sloan-Kettering Institute for Cancer Research: For Hetero Labs Limited Unit V waiver sent on 6/3/2022, answer due 8/2/2022. (Blumenfeld, Jack) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-00678-CFC, 1:22-cv-00688-CFC, 1:22-cv-00696-CFC (rjb) |
| Filing 7 Summons Issued as to Hetero USA, Inc. on 5/27/2022. (twk) |
| Filing 6 Summons Issued as to Hetero Labs Limited Unit V on 5/27/2022. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc. No Parents or Affiliates Listed for The Regents of the University of California, Sloan-Kettering Institute for Cancer Research - filed by Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., Sloan-Kettering Institute for Cancer Research, The Regents of the University of California. |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,445,507 B2; 9,481,663 B2; 9,884,054 B2; 10,052,314 B2; 10,702,508 B2; 10,849,888 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/19/2022. Date of Expiration of Patent: U.S. Patent No. 8,445,507 expires on September 15, 2030; U.S. Patent No. 9,481,663 expires on June 4, 2033; and U.S. Patent Nos. 9,884,054; 10,052,314 and 10,849,888 expire on September 23, 2033. U.S. Patent No. 10,702,508 expires on April 30, 2038. Thirty Month Stay Deadline: 8/14/2025. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Hetero Labs Limited Unit V, Hetero USA, Inc. ( Filing fee $ 402, receipt number ADEDC-3883677.) - filed by Janssen Biotech, Inc., Aragon Pharmaceuticals, Inc., The Regents of the University of California, Sloan-Kettering Institute for Cancer Research. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
